<html>
<head>PUBMED IDs for GATAD2B</head>
<body bgcolor='#C5F0F2'><h1>GATAD2B</h1><a href='https://pubmed.ncbi.nlm.nih.gov/18505370/'>Identification of a linkage disequilibrium block in chromosome 1q associated with BMD in premenopausal white women.</a> May 29  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/24806090/'>Identification of a nuclear protein, LRRC42, involved in lung carcinogenesis.</a> January 16  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25356899/'>De novo mutations in moderate or severe intellectual disability.</a> July 1  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/27732854/'>ZMYND8 Co-localizes with NuRD on Target Genes and Regulates Poly(ADP-Ribose)-Dependent Recruitment of GATAD2A/NuRD to Sites of DNA Damage.</a> October 13  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/28077840/'>Novel GATAD2B loss-of-function mutations cause intellectual disability in two unrelated cases.</a> January 13  2017<br><a href='https://pubmed.ncbi.nlm.nih.gov/28211977/'>1q21.3 deletion involving GATAD2B: An emerging recurrent microdeletion syndrome.</a> February 18  2017<br><a href='https://pubmed.ncbi.nlm.nih.gov/28576827/'>The transcriptional repressor GATAD2B mediates progesterone receptor suppression of myometrial contractile gene expression.</a> June 4  2017<br></body></html>
